Eventide Asset Management is a mission-driven firm, though elevated key-person risk and high fees keep its Parent rating at Average.
Founded in 2008, Eventide takes a faith-based approach to investing. The firm managed USD 6.4 billion in assets as of June 2025 and is employee-owned, with more than 20 of its 74 employees having stakes. However, the business remains tightly controlled by co-CIO Finny Kuruvilla, CEO Robin John, and cofounder Jason Myhre. Key-person risk is pronounced with Kuruvilla, who owns over 50% of the firm and manages most of its assets, including the flagship offering Eventide Gilead as well as Eventide Healthcare & Life Sciences. Previous efforts to appoint comanagers to those strategies haven’t worked, with several since leaving the firm, though the hiring of I-hung Shih in 2024 represents another attempt for Healthcare & Life Sciences.
Efforts to grow and diversify the business are underway. To that end, Eventide has significantly expanded its distribution team and product lineup. In May 2024, the firm launched a private healthcare fund (which charges performance fees), followed later in the year by two exchange-traded funds, which both quickly surpassed USD 100 million in assets. Eventide has plans to launch more ETFs in the future.
The two ETFs launched thus far charge much lower fees than Eventide’s mutual funds, which is a positive step. However, most of the mutual funds remain quite expensive compared with peers, leaving room for further improvement.
Note: This share class' Parent Pillar rating is analyst-driven, as its Branding Name, Eventide (Branding Name ID: BN000008PC), is covered by Morningstar Manager Research.
United States